Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05296252 · ClinicalTrials.gov registry record · NA
Attention and Achievement: A Mind Wandering Investigation
A NA study of Attention Disturbances, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT05296252: Completed NA study of Attention Disturbances, sponsored by University of Houston.
NCT05296252 is a NA study of Attention Disturbances that has completed, run by University of Houston. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05296252, a NA study of Attention Disturbances, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assesses the impact of mind-wandering on reading and math.
Primary Outcome
Participants will answer multiple choice questions regarding the reading material being taught, and the key index will the raw score number correct. The investigators call the scale "Sleep and Dreams" (after the content the participant is reading about), and the possible score range will be 0 (min) to 24 (max), with higher scores meaning better comprehension of the material.
Conditions Studied
Interventions
- BEHAVIORAL mind-wandering intervention
- BEHAVIORAL mind-wandering comparison
Study Locations (1)
Texas
- University of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
What the finished NCT05296252 record still lists
NCT05296252 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Attention Disturbances appearing as the primary indexed condition, and to 2 interventions - of which mind-wandering intervention is the first listed.
NCT05296252 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05296252 about?
NCT05296252 is a clinical study titled "Attention and Achievement: A Mind Wandering Investigation". This study assesses the impact of mind-wandering on reading and math.
What is the current status of trial NCT05296252?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2022-05-11. Estimated completion is 2022-06-15.
What conditions does trial NCT05296252 study?
This clinical trial studies the following conditions: Attention Disturbances.
What interventions are being tested in trial NCT05296252?
The interventions under investigation include: mind-wandering intervention (BEHAVIORAL), mind-wandering comparison (BEHAVIORAL).
Who is sponsoring clinical trial NCT05296252?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05296252 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05296252's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI